NO20031597L - Medisinske aerosolformuleringer - Google Patents

Medisinske aerosolformuleringer

Info

Publication number
NO20031597L
NO20031597L NO20031597A NO20031597A NO20031597L NO 20031597 L NO20031597 L NO 20031597L NO 20031597 A NO20031597 A NO 20031597A NO 20031597 A NO20031597 A NO 20031597A NO 20031597 L NO20031597 L NO 20031597L
Authority
NO
Norway
Prior art keywords
aerosol formulations
medical aerosol
medical
formulations
aerosol
Prior art date
Application number
NO20031597A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031597D0 (no
Inventor
Lesley Mckenzie
James T Lister
Philip Anthony Jinks
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0024711.4A external-priority patent/GB0024711D0/en
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of NO20031597D0 publication Critical patent/NO20031597D0/no
Publication of NO20031597L publication Critical patent/NO20031597L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO20031597A 2000-10-09 2003-04-08 Medisinske aerosolformuleringer NO20031597L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0024711.4A GB0024711D0 (en) 2000-10-09 2000-10-09 Medicinal aerosol formulations
GBGB0122512.7A GB0122512D0 (en) 2000-10-09 2001-09-18 Medical aerosol formations
PCT/US2001/030575 WO2002030394A2 (fr) 2000-10-09 2001-10-01 Formulations medicinales en aerosol

Publications (2)

Publication Number Publication Date
NO20031597D0 NO20031597D0 (no) 2003-04-08
NO20031597L true NO20031597L (no) 2003-05-30

Family

ID=26245133

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031597A NO20031597L (no) 2000-10-09 2003-04-08 Medisinske aerosolformuleringer

Country Status (17)

Country Link
EP (1) EP1324749B1 (fr)
JP (1) JP5021149B2 (fr)
CN (1) CN1635870A (fr)
AR (1) AR030862A1 (fr)
AT (1) ATE320242T1 (fr)
AU (2) AU2002211311B2 (fr)
CA (1) CA2425035A1 (fr)
CZ (1) CZ2003983A3 (fr)
DE (1) DE60118021T2 (fr)
ES (1) ES2260299T3 (fr)
HU (1) HUP0302311A3 (fr)
IL (1) IL155088A0 (fr)
MX (1) MXPA03002991A (fr)
NO (1) NO20031597L (fr)
NZ (1) NZ525054A (fr)
PL (1) PL199420B1 (fr)
WO (1) WO2002030394A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002220857A1 (en) 2000-11-30 2002-06-11 Vectura Limited Particles for use in a pharmaceutical composition
PT2283817T (pt) 2000-11-30 2016-08-22 Vectura Ltd Método de fabrico de partículas para utilização numa composição farmacêutica
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
CA2495689A1 (fr) * 2002-08-23 2004-03-04 Schering Corporation Compositions pharmaceutiques
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) * 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
EP1635845A1 (fr) 2003-06-13 2006-03-22 ALTANA Pharma AG Combination de formoterol et ciclesonide
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1811981B1 (fr) 2004-10-12 2008-08-13 Merck Generics (UK) Limited Procede pour la preparation d'une suspension a pulveriser, caracterise en ce que les particules sont formees a l'interieur du flacon d'aerosol
EP1949891A1 (fr) * 2004-10-12 2008-07-30 Generics (UK) Limited Procédé pour la préparation de formules à suspension pour aérosol, caractérisé en ce que les particles soient formées par précipitation à l'intérieur d'un récipient
RU2007133547A (ru) 2005-02-10 2009-03-20 Глаксо Груп Лимитед (GB) Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
CN100335038C (zh) * 2005-07-25 2007-09-05 江桥 含有生物活性物质和中药成分包封的无机盐纳米粒子的制备方法
CN100435784C (zh) * 2005-07-25 2008-11-26 管晓虹 含有和包封中药成分的无机盐纳米粒子的制备方法
DE102006040535A1 (de) * 2006-08-30 2008-03-13 Beiersdorf Ag Aerosolzubereitung umfassend Peloide
CN101380309B (zh) * 2007-09-03 2012-05-09 李浩莹 一种定量吸入气雾剂及其制备方法
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
US20140113877A1 (en) 2011-06-15 2014-04-24 Takeda Gmbh Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compounds
EP2721030B1 (fr) 2011-06-17 2015-12-16 Takeda GmbH Nouveaux dérivés de phthalazinone-pyrrolopyrimidinecarboxamides
WO2018069210A1 (fr) 2016-10-10 2018-04-19 Takeda Gmbh Tétrahydrofuro [3,4-c] isoquinolines en tant qu'inhibiteurs de pde4
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN110755414A (zh) * 2019-11-12 2020-02-07 南京华盖制药有限公司 一种酒石酸阿福特罗气雾剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
WO1996025918A1 (fr) * 1995-02-24 1996-08-29 Nanosystems L.L.C. Aerosols contenant des dispersions de nanoparticules
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions

Also Published As

Publication number Publication date
EP1324749A2 (fr) 2003-07-09
ATE320242T1 (de) 2006-04-15
NO20031597D0 (no) 2003-04-08
NZ525054A (en) 2004-11-26
HUP0302311A2 (hu) 2003-10-28
MXPA03002991A (es) 2004-05-05
IL155088A0 (en) 2003-10-31
DE60118021D1 (de) 2006-05-11
HUP0302311A3 (en) 2006-07-28
ES2260299T3 (es) 2006-11-01
DE60118021T2 (de) 2006-10-26
AU2002211311B2 (en) 2006-08-31
CZ2003983A3 (cs) 2003-09-17
EP1324749B1 (fr) 2006-03-15
JP2004510808A (ja) 2004-04-08
PL199420B1 (pl) 2008-09-30
AU1131102A (en) 2002-04-22
WO2002030394A3 (fr) 2003-01-30
PL361135A1 (en) 2004-09-20
CA2425035A1 (fr) 2002-04-18
AR030862A1 (es) 2003-09-03
JP5021149B2 (ja) 2012-09-05
WO2002030394A2 (fr) 2002-04-18
CN1635870A (zh) 2005-07-06

Similar Documents

Publication Publication Date Title
NO20031597D0 (no) Medisinske aerosolformuleringer
DK1317177T3 (da) Desinficerende formuleringer
AR028291A1 (es) Formulaciones oftalmicas
DE10192161T1 (de) Medizinischer Führungsdraht
NO20033556L (no) Farmasöytiske formuleringer
EE05421B1 (et) Fulvestrandi formulatsioonid
DK1199054T3 (da) Væskefrakturhånddel
DE50104433D1 (de) Desodorierende Zubereitungen
NO20025578D0 (no) Medisinsk innretning
PL364773A1 (pl) Inhalator dozujący ksynafonian salmeterolu
DE50111900D1 (de) Medizinisches implantat
FR2815535B1 (fr) Implant pediculaire
DE60209020D1 (de) Pestizide formulierungen
DE50101916D1 (de) Flüssige formulierungen
NO20015670L (no) Forbedrede farmasöytiske formuleringer
IS6398A (is) Lyfjablöndur
DE60123364D1 (de) Sterilisierungsmittelverdampfer
ATE268116T1 (de) Mesotrion-formulierungen
ATE270044T1 (de) Fungizide formulierung
NO20030946D0 (no) Medisinske sammensetninger
FR2803509B1 (fr) Prothese metatarso-phalangienne
GB0024711D0 (en) Medicinal aerosol formulations
SE0004844D0 (sv) Länkhjul
DK1267974T3 (da) Inhalationsapparat
GB0007070D0 (en) Deodorant formulations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application